Skip to main content

Advertisement

SpringerLink
Log in

Clinical Ambiguities—Ongoing Questions

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Many factors need to be considered when choosing the mode of delivery of immunoglobulin (IgG) replacement therapy for a given patient with primary immunodeficiency disease (PIDD). Despite some general guidance as provided in the previous discussions, a number of ongoing questions remain. This article attempts to provide some answers and clarification for clinical situations in which the choice of intravenous IgG (IVIG) or subcutaneous IgG (SCIG) may be ambiguous.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Orange JS, Grossman WJ, Navickis RJ, Wilkes MM. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol. 2010;137:21–30.

    Article  PubMed  CAS  Google Scholar 

  2. Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010;125:1354–60.e4.

    Article  PubMed  CAS  Google Scholar 

  3. Chen Y, Stirling RG, Paul E, Hore-Lacy F, Thompson BR, Douglass JA. Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. J Allergy Clin Immunol. 2011;127:1414–7.

    Article  PubMed  Google Scholar 

  4. Shapiro R. Subcutaneous immunoglobulin therapy by rapid push is preferred to infusion by pump: a retrospective analysis. J Clin Immunol. 2010;30:301–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Washington School of Medicine, 1900 9th Ave., C9S-7, Seattle, WA, 98101-1304, USA

    Troy R. Torgerson

  2. Seattle Children’s Research Institute, Seattle, WA, USA

    Troy R. Torgerson

  3. Steven and Alexandra Cohen Children’s Medical Center of New York, North Shore-Long Island Jewish Health System, Great Neck, NY, USA

    Vincent R. Bonagura

  4. Midwest Immunology Clinic, Plymouth, MN, USA

    Ralph S. Shapiro

Authors
  1. Troy R. Torgerson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent R. Bonagura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ralph S. Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Troy R. Torgerson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Torgerson, T.R., Bonagura, V.R. & Shapiro, R.S. Clinical Ambiguities—Ongoing Questions. J Clin Immunol 33 (Suppl 2), 99–103 (2013). https://doi.org/10.1007/s10875-012-9851-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-012-9851-4

Keywords

Search

Navigation